Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis

Mario Pezzi; Anna Maria Scozzafava; Anna Maria Giglio; Renata Vozzo; Patrizia Dina Casella; Simona Paola Tiburzi; Lucio Cosco; Mario Verre

首页> 外文期刊>Case Reports in Obstetrics and Gynecology >Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis

【24h】

Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis

机译：在Puerperal Sepsis中使用Ceftolozane / Tazobactam在脓毒症患者的情况下

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Multiresistant bacteria infections cause widespread morbidity and mortality and lead to an increase in expenses for hospital stays and complications. We describe the case of a 27-year-old patient with puerperal sepsis after cesarean section due to Escherichia coli complicated by multiresistant Klebsiella ESBL-producing superinfection with septic shock and multiple organ dysfunction syndrome, successfully treated with ceftolozane/tazobactam.

机译：多思科的细菌感染导致普遍的发病率和死亡率，并导致住院费用的费用增加。我们描述了在剖宫产后患有Puerperal Sepsis的27岁患者的案件，由于大肠杆菌和多个器官功能障碍综合征产生了多思科Klebsiella ESBL的SuperInfection，用CIFTOLOZANE / TAZOBACTAM成功处理。

著录项

来源
《Case Reports in Obstetrics and Gynecology》 |2019年第3期|共6页
作者
Mario Pezzi; Anna Maria Scozzafava; Anna Maria Giglio; Renata Vozzo; Patrizia Dina Casella; Simona Paola Tiburzi; Lucio Cosco; Mario Verre;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock [J] . Christina Le, Frank Chu, Ronald Dunlay, The American journal of emergency medicine . 2018,第8期

机译：评估患有严重脓毒症和脓毒症休克患者ED患者的万古霉素和哌啶蛋白-Tazobactam
2. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J] . Shankar-Hari Manu, Phillips Gary S., Levy Mitchell L., JAMA: the Journal of the American Medical Association . 2016,第8期

机译：为败血症和败血性休克（Sepsis-3）的第三个国际共识定义制定新的定义和评估败血性休克的新临床标准
3. Outcomes in severe sepsis and patients with septic shock do not matter! PIRO is a score to treat severe septic and septic shock patients not to measure outcomes. [J] . Rubulotta F, Ramsay G Critical care medicine . 2012,第2期

机译：严重败血症和败血性休克患者的结局无所谓！ PIRO是治疗严重败血症和败血性休克患者而不评估结局的评分。
4. Relation of heart rate variability to serum levels of C-reactive protein in patients with severe sepsis and septic shock [C] . Papaioannou V.P., Dragoumanis C.D., Pneumatikos I.P. Computers in Cardiology, 2009 . 2009

机译：严重败血症和败血性休克患者心率变异性与血清C反应蛋白水平的关系
5. Integration of Recognition, Diagnostic, and Treatment Strategies between Prehospital Emergency Medical Services and Hospital Emergency Departments in the Management of Patients with Acute Sepsis and Septic Shock [D] . Duguay, Darren Caine. 2019

机译：在急性脓毒症和脓毒症休克患者管理中，在急性应急医疗服务和医院急诊部门之间的识别，诊断和治疗策略的整合
6. Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis [O] . Mario Pezzi, Anna Maria Scozzafava, Anna Maria Giglio, 2019

机译：产后败血症脓毒性休克时使用头孢洛氮/他唑巴坦
7. Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis [O] . Mario Pezzi, Anna Maria Scozzafava, Anna Maria Giglio, 2019

机译：在Puerperal Sepsis中使用Ceftolozane / Tazobactam在脓毒症患者的情况下

Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis

摘要

著录项

相似文献

相关主题

期刊订阅